CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Davids Productions

Davids Productions is a Montville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ameriplan USA

How to make money Ameriplan and save on dental, vision, and prescription

Garden View Assisted Living

Garden View Assisted Living is a New Iberia, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Choice Home Medical Equipment

Choice Home Medical Equipment is a Greensboro, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Massachusetts Hospital Association

Massachusetts Hospital Association is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Burlington, MA. To find more information about Massachusetts Hospital Association, please visit www.mhalink.org